Rivanna Medical announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market Accuro, a handheld and untethered smart phone-sized ultrasound device. Accuro is designed to guide spinal anesthesia with automated 3-D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies.
The American College of Radiology (ACR) applauds the Centers for Medicare & Medicaid Services (CMS) for proposing steps toward a more evidence-base imaging policy in the Medicare Physician Fee Schedule proposed rule. The ACR is particularly encouraged that CMS is considering proposed actions with ACR input regarding appropriate use criteria (AUC) and clinical decision support (CDS) development and digital practice expense inputs regarding the transition from film to digital radiology.
Mirada Medical and collaborators from the University Medical Center, Groningen, The Netherlands, will present new research on quality assurance of deformable image registration (DIR) at the annual meeting of the American Association of Medical Physicists (AAPM). Accurate definition of targets and critical structures is essential for the planning and delivery of radiation therapy and radiosurgery. DIR is increasingly utilized during treatment planning to aid in this process.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
PHS Technologies Group LLC, a division of PACSHealth LLC, announced that it will integrate VirtualDose CT (computed tomography) software from Virtual Phantoms Inc. into their DoseMonitor product.
Accuray Inc. and RaySearch Laboratories AB announced they have signed a long-term collaboration agreement allowing Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch. Under the contract, Accuray will have the opportunity to offer RayCare in several designated major radiation therapy markets, making available a fully-integrated solution with the TomoTherapy and CyberKnife System product portfolios.
![](/sites/default/files/styles/content_feed_medium/public/FCT%20iStream%203qtr%20with%20Tech%20RGB_1.png?itok=M9tQB8sN)
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
The U.S. House of Representatives July 10 passed its version of the 21st Century Cures Act (H.R. 6), designed to improve the U.S. healthcare innovation infrastructure. It was approved in a bipartisan vote of 344-77. The bill calls for providing resources to researchers working on next-generation medical devices and therapies. The legislation is aimed at addressing concerns that U.S. healthcare innovation is lagging behind the rest of the world due to large amounts of time-consuming and expensive regulatory oversight requirements that some feel are stifling innovation and the ability of startup companies to bring new products to market.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
The Centers for Medicare & Medicaid Services (CMS) and the American Medical Association (AMA) announced efforts to help physicians prepare for the nationwide switch from ICD-9 to ICD-10 ahead of the October 1 deadline. In response to requests from the provider community, CMS is releasing additional guidance that will allow for flexibility in the claims auditing and quality reporting process as the medical community gains experience using the new ICD-10 code set for medical diagnoses and inpatient hospital procedures.
Health data security and patient engagement are top priorities for the nation's hospitals, according to results of the 17th annual HealthCare's Most Wired Survey. The annual survey was released by the American Hospital Association's Health Forum and the College of Healthcare Information Management Executives (CHIME).
Women with cervical or endometrial cancer who require treatment to the para-aortic (PA) lymph nodes can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity, according to a new study. Findings were published in the July-August 2015 issue of Practical Radiation Oncology (PRO), the American Society for Radiation Oncology’s (ASTRO’s) journal focused on the clinical practice of radiation oncology.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
Lexmark announced that it has received 510(k) Class II clearance from the U.S. Food and Drug Administration (FDA) for Lexmark NilRead, a Web-based, zero-footprint enterprise diagnostic viewer. The NilRead viewer is available in multiple configurations – core, clinical and interpretation – covering different workflows, ranging from the distribution of imaging studies and reports within the enterprise to full primary interpretation workflows in decoupled enterprise image management implementations.
Carestream is expanding into new imaging modalities — cone beam computed tomography (CBCT) and ultrasound — and key advances in these areas will be demonstrated at the Association for Medical Imaging Management (AHRA) conference July 19-22. For cone beam CT, which is currently undergoing patient studies, a conceptual scale model will be on display.
Civco Medical Solutions will showcase new patient positioning and immobilization innovations to attendees of the American Association of Physicists in Medicine (AAPM) annual meeting July 12 – 16 in Anaheim, California.
Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...
Mercom Capital Group llc, a global communications and research firm, released its report on funding and mergers and acquisitions (M&A) activity for the Healthcare Information Technology (IT)/Digital Health sector for the second quarter of 2015. The comprehensive report covers deals of all sizes across the globe.
Blue Earth Diagnostics Ltd (BED) announced it has received both U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Orphan Drug Designation (ODD) for fluciclovine (18F) in the diagnosis of glioma. Fluciclovine is an investigational positron emission tomography (PET) radiopharmaceutical based on a synthetic amino acid, which appears to be preferentially taken up in a number of cancer indications, including in prostate cancer and brain tumors.
![This latest version of Ensight expands the suite of available use cases and provides additional capabilities.](/sites/default/files/styles/content_feed_medium/public/Series%20Impacted%20by%20Endex.png?itok=9v56GnsU)
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Agfa HealthCare announced that it will launch its new mobile digital radiography (DR) system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting. FreeView technology creates better maneuverability and ease of use by offering a telescoping column for an unobstructed view while driving the mobile DR system.
After comparing more than 20,000 brain scans, researchers have identified differences between traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) despite both conditions sharing common symptoms.
Findings from a study in the July 7 issue of the Journal of the American Medical Association (JAMA) suggest that management approaches for localized, low-risk prostate cancer have improved after years of overtreatment. According to the study, rates of active surveillance/watchful waiting increased sharply in 2010 through 2013, and high-risk disease was more often treated appropriately with potentially curative local treatment rather than androgen deprivation alone.
Konica Minolta Inc. announced that it has acquired Sawae Technologica Ltda., an X-ray system equipment manufacturer based in Minas Gerais, Brazil, through its Brazilian healthcare sales company, Konica Minolta Healthcare do Brazil.
Planmed introduces a new mammography unit, Planmed Clarity 3D, which utilizes advanced digital breast tomosynthesis (DBT) technology. DBT enables enhanced diagnostics, especially for patients with denser fibroglandular breast tissue.
The first randomized trial investigating the additional value of magnetic resonance imaging (MRI) for screening women with dense breasts, is featured in the current issue of Radiology. The article, “MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50–75 Years with Extremely Dense Breasts: The DENSE Trial Study Design,†presents the rationale and design of the DENSE Trial. Run by Carla van Gils, M.D., and Wouter Veldhuis, M.D., from University Medical Center Utrecht (UMCU) in the Netherlands, the trial seeks to determine the effectiveness of screening with mammography and MRI compared to mammography alone in women who have extremely dense breasts.